HIPRA is a multinational, veterinary biopharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service. The company has a solid international presence, encompassing multiple commercial subsidiaries with a global distribution network. Through its HIPRA Biotech Services division, the company provides CDMO services to pharmaceutical and biotechnology companies, delivering comprehensive contract development and commercial manufacturing across a wide range of biologic technologies and modalities.